C
Chris Smith
Guest
- A new coronavirus drug type is in clinical trials, with researchers studying its efficacy at blocking the virus from infecting cells.
- PIKfyve kinase inhibitors like vacuolin-1 and apilimod have been found in lab tests to block the SARS-CoV-2 virus from infecting human cells.
- Scientists are now looking to replicate the same results in human trials.
Scientists from all over the world have come up with all sorts of ways to fight the novel coronavirus, targeting the pathogen with various existing drugs and new compounds in an attempt to prevent it from infecting cells. Some of these drugs failed in key tests, with hydroxychloroquine being the most prominent failure so far. Others have shown some efficacy, like remdesivir, dexamethasone, and blood thinners. Several new treatments are still in testing and could yield results in the coming months. It’s not just vaccines the world needs to end the pandemic, after all. Effective COVID-19 therapies that can significantly reduce complications and deaths are also needed to help those people who will continue to get infected.
Researchers are now studying vacuolin-1 and apilimod, two similar drugs that might be able to block the novel coronavirus from infecting cells.
Continue reading...
Today's Top Deals
- The black coronavirus face masks everyone wants are only 46¢ today at Amazon
- CDC guidelines say everyone needs these 7 coronavirus essentials
- Actual Purell hand sanitizer is in stock and shipping immediately from Amazon
Trending Right Now:
- New guidelines say coronavirus antibody tests are pointless
- Bill Gates says the coronavirus could kill millions of people who aren’t even infected
- Zoom is down for thousands of people on Monday morning
Doctors found a new drug that might block coronavirus infections originally appeared on BGR.com on Sun, 23 Aug 2020 at 14:07:54 EDT. Please see our terms for use of feeds.
Via BRG - Boy Genius Report